First Marketing Authorization secured by Venus Remedies for Plerixafor in any market Advances the company's shift into higher value specialty injectables across regulated markets Plerixafor is a stem cell mobilization therapy used in autologous transplantation for multiple myeloma and non-Hodgkin lymphoma Venus Remedies Limited (NSE:
By Dr. Sumol Ratna, Assistant Professor, Department of Medicine, NIIMS Medical College & Hospital In our present times, when everything is on a fast track, health is often given second priority in favor of deadlines, routines, and responsibilities. Many people ignore regular health checks, assuming
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
